Clinical Research Directory
Browse clinical research sites, groups, and studies.
Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study
Sponsor: Cedars-Sinai Medical Center
Summary
The purpose of this study is to see if a special light treatment, called photobiomodulation, can help people with memory problems such as Mild Cognitive Impairment or Mild Dementia due to Alzheimer's disease. The light is given to the forehead using an FDA-cleared medical device. This device is cleared to provide topical heating to elevate tissue temperature for temporary relief of muscle and joint pain, muscle spasm and stiffness associated with arthritis. It also increases blood circulation and relaxes muscle tissue. This device is being used "off-label," meaning it will be used in a way that is different than its cleared use. We want to learn whether this light treatment can improve executive function, and whether it changes certain inflammatory and neurodegeneration related signals in the blood. To do this, we will apply the photobiomodulation device to your forehead. We will also ask you questions and give you cognitive tests before and after light treatment. We will also collect blood samples before and after treatment.
Official title: A Longitudinal Study Investigating the Effects of Photobiomodulation (PBM) on Cognitive Function and Alzheimer's Disease (AD)-Related Biomarkers in Individuals With Mild Cognitive Impairment (MCI) or Dementia Due to AD
Key Details
Gender
All
Age Range
55 Years - 89 Years
Study Type
INTERVENTIONAL
Enrollment
45
Start Date
2025-12-25
Completion Date
2026-10
Last Updated
2025-11-19
Healthy Volunteers
No
Conditions
Interventions
Photobiomodulation
1064nm transcranial photobiomodulation
Locations (1)
CSMC
Los Angeles, California, United States